Published in Scand J Clin Lab Invest on January 01, 2006
Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA (2013) 2.98
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2010) 2.28
Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults. Am J Epidemiol (2012) 1.34
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer (2009) 1.26
Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate. Dermatoendocrinol (2012) 1.13
Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab (2011) 1.12
Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients (2013) 1.09
Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2012) 1.08
Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions. Int J Endocrinol (2014) 1.05
Determinants of serum levels of vitamin D: a study of life-style, menopausal status, dietary intake, serum calcium, and PTH. BMC Womens Health (2013) 1.02
Seasonal variations in serum 25-hydroxy vitamin D levels in a Swedish cohort. Endocrine (2015) 1.01
Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environ Health Perspect (2013) 0.93
Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women. Int J Cancer (2010) 0.93
Dietary, lifestyle, and genetic determinants of vitamin D status: a cross-sectional analysis from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. Eur J Nutr (2013) 0.92
Vitamin D status among adults in Germany--results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health (2015) 0.85
Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women. J Nutr (2012) 0.81
VITAMIN D-BINDING PROTEIN IN HEALTHY PRE- AND POSTMENOPAUSAL WOMEN: RELATIONSHIP WITH ESTRADIOL CONCENTRATIONS. Endocr Pract (2015) 0.80
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
Heart failure in patients treated with bisphosphonates. J Intern Med (2013) 2.00
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (2001) 1.84
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand (1980) 1.65
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol (1996) 1.60
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr (2005) 1.53
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem (2001) 1.48
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
Sixteen-year mortality in patients with affective disorder commenced on lithium. Br J Psychiatry (2000) 1.43
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study. J Intern Med (2012) 1.41
Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis. J Am Acad Dermatol (1991) 1.40
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int (2009) 1.33
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Antidepressant medications and osteoporosis. Bone (2012) 1.28
Characterization of an epithelial approximately 460-kDa protein that facilitates endocytosis of intrinsic factor-vitamin B12 and binds receptor-associated protein. J Biol Chem (1997) 1.27
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23
Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation (1997) 1.23
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone (1994) 1.19
Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17
Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms. J Bone Miner Res (2000) 1.17
Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17
Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16
Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res (2001) 1.15
Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14
Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12
Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int (2013) 1.11
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11
Early changes in muscle strength after total knee arthroplasty. A 6-month follow-up of 30 knees. Acta Orthop Scand (1999) 1.11
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10
Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood (2001) 1.10
The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg (2000) 1.09
Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09
Holotranscobalamin--a first choice assay for diagnosing early vitamin B deficiency? J Intern Med (2005) 1.08
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment. Acta Psychiatr Scand (1980) 1.08
Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology (Berl) (1982) 1.08
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients. Br J Cancer (2004) 1.07
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone (1989) 1.06
Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study. J Bone Miner Res (2001) 1.06
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int (2006) 1.06
Serum lithium concentrations around the clock with different treatment regimens and the diurnal variation of the renal lithium clearance. Acta Psychiatr Scand (1981) 1.06
Mortality in Cushing's syndrome: a systematic review and meta-analysis. Eur J Intern Med (2011) 1.06
Reduced relative risk of fractures among users of lithium. Calcif Tissue Int (2005) 1.05
An evaluation of the quantitative parameters applied in bone histology. Acta Pathol Microbiol Scand A (1978) 1.02
A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma. Scand J Haematol (1975) 1.02
Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder. Mol Psychiatry (1998) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02